ADMA Biologics Inc (ADMA) earnings · P/E 15, rev $510.2M
These earnings events as JSON? API free 100/dayADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
This ADMA earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ADMA revenue for 2025-12-31 was $510.2M. Net income was $146.9M. Revenue was up 19.6% from 2024-12-31 to 2025-12-31. ADMA currently screens at market cap $4.39B and trailing P/E 15.3.
When the next ADMA 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 19.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ADMA research stays on the stock page; the tape stays on the quote page.
ADMA earnings FAQ
What are ADMA's latest revenue and net income?
Latest cached ADMA Biologics Inc (ADMA) revenue for Dec 31, 2025 was $510.2M. Net income was $146.9M. Statements: https://lician.com/financials/adma
What is ADMA's latest diluted EPS?
Latest cached ADMA Biologics Inc (ADMA) diluted EPS for Dec 31, 2025 was $0.60.
What period does the latest ADMA earnings print cover?
The latest cached ADMA Biologics Inc (ADMA) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did ADMA revenue change from the prior cached period?
Cached ADMA Biologics Inc (ADMA) revenue was up 19.6% from $426.5M (Dec 31, 2024) to $510.2M (Dec 31, 2025). Statements: https://lician.com/financials/adma
What is ADMA's P/E ratio?
ADMA Biologics Inc (ADMA) trailing P/E is 15.3 on the latest cached fundamentals snapshot.
Where are ADMA earnings listed?
Cached earnings facts for ADMA Biologics Inc (ADMA) are listed at https://lician.com/earnings/adma. Statements: https://lician.com/financials/adma
Not investment advice.